Amniotic fluid lamellar body count and its sensitivity and specificity in evaluating of fetal lung maturity.

This prospective study was designed to perform lamellar body count of amniotic fluid to evaluate fetal lung maturity. Lamellar body counts of 80 amniotic fluid samples from 80 pregnant women (28-40 weeks of gestation) were evaluated. After delivery, each infant was evaluated for any evidence of respiratory distress syndrome. Standard clinical and radiographic criteria were used to diagnose respiratory distress syndrome, and the diagnosis was confirmed by reviewing newborn records. Twenty (25%) infants delivered within 24 hours of sample collection developed RDS. Lamellar body count more than 50,000/microl predicted pulmonary maturity. Seventeen out of 20 respiratory distress syndrome cases had been predicted correctly. The negative predictive value of lamellar body count>50,000/microl was 93% and positive predictive value was 48% and the sensitivity for prediction of RDS was 85% and specificity was 70%. Lamellar body count can be used as a favourable predictor of fetal lung maturity because it is quick, simple and universally available. Also it can be used as an extremely inexpensive, reliable screening test for evaluating fetal lung maturity.     

Evaluating the UVA protection of sunscreens

Because the protection factor of sunscreens concerns only UVB protection, usually nothing is known about the protection offered in the UVA range. Using different methods, we compared six commercially available sunscreens to determine the UVA protection factor and, thus, to select the most appropriate sunscreen. Two clinical methods on human skin (inhibition of UVA-induced tanning with the use of a high-intensity UVA source and inhibition of methoxsalen plus UVA-induced phototoxicity) were compared with a method in animals (inhibition of UVA-induced sunburn cell production in mice treated with methoxsalen) and with two in vitro techniques (solution-dilution and sandwich spectrophotometry). We conclude that all five methods used give a quantitative estimate of UVA protection, but none can be accepted as a standard because the UVA protection factor varies according to the method used and the reading time.     

Modification of sunburn cell production in 8-MOP sensitized mouse epidermis: a method of assessing UVA sunscreen efficacy

The UVA(320-400 nm) photoprotection of four commercially available sunscreens with different sun protection factors was evaluated in 8-methoxypsoralen (8-MOP) treated mouse epidermis with the number of sunburn cells (SBCs) as the end-point. SBC production in 8-MOP sensitized mouse epidermis with and without application of sunscreens is dose-related. The difference between the slopes of the dose-response curves of the control group and the four sunscreens was highly significant (p less than 0.001). It appears that the SBC production was modified both by the dose of the UVA irradiation administered and by the UVA photoprotection of the four sunscreens. It could be concluded that the number of SBCs in 8-MOP sensitized mouse epidermis is a useful parameter to quantify the degree of UVA photoprotection of sunscreens.     

Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome

Aim.?Polycystic ovary syndrome (PCOS) is associated with the clustering of states including insulin resistance (IR), obesity, elevated blood pressure, and dyslipidemia that are termed as metabolic syndrome (MBS). This study was designed to assess the differences between homeostatic model assessment (HOMA) values in PCOS and healthy women.

Methods.?In a case–control study, 55 women with PCOS and 59 women with normal cycles (control group) aged 15–40 years old were evaluated. In all the subjects (after obtaining written informed consent), blood pressure, body weight, height, body mass index (BMI), waist /hip ratio(WHR) and fasting blood glucose (FBG), triglycerides (TG), HDL, C-peptide, insulin, HOMA Index, and FGIR (fasting glucose to insulin ratio) were measured.

Results.?In this study, the prevalence of MBS was significantly higher in PCOS group compared with the control group (p = 0.028). There were no significant differences in age, waist/hip ratio, fasting glucose, insulin, and C-peptide levels between patients with PCOS and control group. Furthermore, the prevalence of impaired fasting glucose (IFG) and the mean of HOMA and FGIR did not differ significantly between PCOS and control group.

Conclusion.?Criteria of MBS are frequently present in young women with PCOS and may be more useful as a prognostic factor than IR indexes in this age group. We suggest evaluation of IR in older age women with PCOS.     

Tribulus terrestris for treatment of sexual dysfunction in women: randomized double-blind placebo - controlled study

Background

Tribulus terrestris as a herbal remedy has shown beneficial aphrodisiac effects in a number of animal and human experiments. This study was designed as a randomized double-blind placebo-controlled trial to assess the safety and efficacy of Tribulus terrestris in women with hypoactive sexual desire disorder during their fertile years. Sixty seven women with hypoactive sexual desire disorder were randomly assigned to Tribulus terrestris extract (7.5 mg/day) or placebo for 4 weeks. Desire, arousal, lubrication, orgasm, satisfaction, and pain were measured at baseline and after 4 weeks after the end of the treatment by using the Female Sexual Function Index (FSFI). Two groups were compared by repeated measurement ANOVA test.

Results

Thirty women in placebo group and thirty women in drug group completed the study. At the end of the fourth week, patients in the Tribulus terrestris group had experienced significant improvement in their total FSFI (p < 0.001), desire (p < 0.001), arousal (p = 0.037), lubrication (p < 0.001), satisfaction (p < 0.001) and pain (p = 0.041) domains of FSFI. Frequency of side effects was similar between the two groups.

Conclusions

Tribulus terrestris may safely and effectively improve desire in women with hypoactive sexual desire disorder. Further investigation of Tribulus terrestris in women is warranted.     

A randomised placebo-controlled trial to determine the effect of vitamin E in treatment of primary dysmenorrhoea

Objective To determine whether vitamin E is effective in the treatment of primary dysmenorrhoea.
Design A randomised placebo-controlled trial.
Participants One hundred girls, aged 16–18 years old who suffered from primary dysmenorrhoea, among 1000 students attending a public high school in Region 5 in the Greater Tehran Municipality.
Methods Fifty girls were given 500 units of vitamin E (five tablets) per day, and 50 were given five placebo tablets per day. The treatment began two days before the beginning of menstruation and continued through the first three days of bleeding. The severity of pain before and after the treatment was studied. Treatment in both groups was carried out in two consecutive menstrual periods.
Results The severity of pain in the two groups was reduced after treatment, but the reduction was greater in the group treated with vitamin E. These differences were maintained in the second month of therapy.
Conclusion Both placebo and vitamin E are effective in relieving symptoms due to primary dysmenorrhoea, but the effects of vitamin E are more marked.